College: St Cross College
Location: Oxford
Site: Churchill Hospital
Research Building: Botnar Research Centre
Dr. Jeffrey Rubasingham is a specialist registrar in Clinical Oncology and the lead clinical research fellow for CEeDD, a National Institute of Health Research (NIHR) funded early-phase clinical trial investigating ultrasound-enhanced drug delivery for colorectal liver metastases. Concurrently, he is pursuing a DPhil in Biomedical Engineering (funded by Cancer Research UK) under the supervision of Professors Constantin Coussios, Robert Carlisle, and Rachel Kerr. His research focuses on the enhancement and monitoring of antibody therapy using ultrasound-mediated cavitation and passive acoustic mapping.
Dr. Rubasingham obtained his primary medical degree from the University of Birmingham and completed a master’s degree in Genomics at the University of Cambridge, where he researched histopathological associations of KRAS mutations in colorectal cancer, funded by Health Education England. He is a member of the Royal College of Surgeons, the Royal College of Physicians, and a fellow of the Royal College of Radiologists.
- Enhancement and monitoring of antibody therapy in cancer patients by ultrasound-mediated cavitation and passive acoustic mapping.
- Clinical translation of ultrasound-mediated immunomodulation in solid tumours using innovative trial design.
BUBBL
Professor Robert Carlisle - Academic
Professor Constantin Coussios - Academic
Dr Michael Gray - Academic
Dodwell D, Coles CE, Earl H, Anderson BO, Barrios CH, Bienz M, Bliss JM, Cameron DA, Cardoso F, Cui W, Francis PA, Jagsi R, Knaul FM, McIntosh SA, Phillips K-A, Radbruch L, Thompson MK, André F, Abraham JE, Bhattacharya IS, Franzoi MA, Drewett L, Fulton A, Kazmi F, Inbah Rajah D, Mutebi M, Ng D, Ng S, Olopade OI, Rosa WE, Rubasingham J, Spence D, Stobart H, Vargas Enciso V, Vaz-Luis I, et al. (2024)
Cooper S, Denholm M, Malek AS, Rubasingham JA, Tsang D, et al. (2024)
Lyons B, Balkaran JPR, Dunn-Lawless D, Lucian V, Keller SB, O'Reilly CS, Hu L, Rubasingham J, Nair M, Carlisle R, Stride E, Gray M, Coussios C, et al. (2023)
Coles CE, Anderson BO, Cameron D, Cardoso F, Horton R, Knaul FM, Mutebi M, Lee N, Lancet Breast Cancer Commission , et al. (2022)
Rubasingham J, Gemmill J, James E, Twyman N, Gatfield E, Barnett G, Benson R, Jadon R, et al. (2022)
Tharmakulasingam S, Rubasingham J, Mithra S, Cooper S, Malek A, Dancey G, Islam M, et al. (2020)
Rubasingham J, Marzouk S, Madhavan K, Sioftanos G, Liyanage SH, et al. (2020)
Rubasingham J, Malek A, Cooper S, Mithra S, Dancey G, Islam M, et al. (2020)
Muthukumar D, Sheen L, Rubasingham J, Saunders E, et al. (2019)
Muthukumar D, Saunders E, Rubasingham J, Nagarajah V, et al. (2019)